The 77 references in paper V. Moroz V., D. Silachev N., E. Plotnikov Yu., L. Zorova D., I. Pevzner B., O. Grebenchikov A., V. Likhvantsev V., В. Мороз В., Д. Силачев Н., Е. Плотников Ю., Л. Зорова Д., И. Певзнер Б., О. Гребенчиков А., В. Лихванцев В. (2013) “Механизмы повреждения и защиты клетки при ишемии/реперфузии и экспериментальное обоснование применения препаратов на основе лития в анестезиологии // Mechanisms of Cell Damage and Protection in Ischemia/Reperfusion and Experimental Rationale for the Use of Lithium-Based Preparations in Anesthesiology” / spz:neicon:reanimatology:169

1
Гусев Е. И. , Скворцова В. И. , Стаховская Л. В. Проблемы инсульта в Российской Федерации: время активных совместных действий. Журн. неврологии и психиатрии им. Корсакова. 2007; 107: 4—10.
(check this in PDF content)
2
Лихванцев В. В., Мороз В. В., Гребенчиков О. А., Гороховатский Ю. И., Заржецкий Ю. В., Тимошин С. С., Левиков Д. И., Шайбакова В. Л. Ишемическое и фармакологическое прекондиционирование (часть 1). Общая реаниматология. 2011; 7 (6): 59—65.
(check this in PDF content)
3
Лихванцев В. В., Мороз В. В., Гребенчиков О. А., Гороховатский Ю. И., Заржецкий Ю. В., Тимошин С. С., Левиков Д. И., Шайбакова В. Л. Ишемическое и фармакологическое прекондиционирование (часть 2). Общая реаниматология. 2012; 8 (1): 61—67.
(check this in PDF content)
4
Shohami E., Gati I., BeitTYannai E., Trembovler V., Kohen R. Closed head injury in the rat induces whole body oxidative stress: overall reducing antioxidant profile. J. Neurotrauma. 1999; 16 (5): 365—376.
(check this in PDF content)
5
Himmelfarb J., Ikizler T. A. Acute kidney injury: changing lexicography, definitions, and epidemiology. Kidney Int. 2007; 71 (10): 971—976.
(check this in PDF content)
6
Schneider A., Bottiger B. W., Popp E. Cerebral resuscitation after cardio! circulatory arrest. Anesth. Analg. 2009; 108 (3): 971—979.
(check this in PDF content)
7
Lim C., Alexander M. P., LaFleche G., Schnyer D. M., Verfaellie M. The neurological and cognitive sequelae of cardiac arrest. Neurology. 2004; 63 (10): 1774—1778.
(check this in PDF content)
8
Alem A. P., de Vos R., Schmand B., Koster R. W. Cognitive impair! ment in survivors of out!of!hospital cardiac arrest. Am. Heart J. 2004; 148 (3): 416—421.
(check this in PDF content)
9
Корниенко А. Н., Добрушина О. Р., Зинина Е. П. Профилактика кар! диальных осложнений внесердечных операций. Общая реаниматоT логия. 2011; 7 (5): 57—66.
(check this in PDF content)
10
Табакьян Е. А. , Партигулов С. А. , Савушкина Т. Н. , Лепилин М. Г. , АкT чурин Р. С. Гемофильтрация и гемодиализ в профилактике и лече! нии острой почечной недостаточности после операций на сердце с искусственным кровообращением. Общая реаниматология. 2012; 8 (1): 36—40.
(check this in PDF content)
11
Nolan J. P., Neumar R. W., Adrie C., Aibiki M., Berg R. A., Böttiger B. W., Callaway C., Clark R. S., Geocadin R. G., Jauch E. C., Kern K. B., Laurent I.,Longstreth W. T., Merchant R. M., Morley P., Morrison L. J., Nadkarni V., Peberdy M. A., Rivers E. P., RodriguezTNunez A., Sellke F. W., Spaulding C., Sunde K., Vanden Hoek T. Post!cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication: a sci! entific statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council
(check this in PDF content)
12
Cadenas E., Sies H. Oxidative stress: excited oxygen species and enzyme activity. Adv. Enzyme Regul. 1985; 23: 217—237.
(check this in PDF content)
13
Зоров Д. Б., Банникова С. Ю., Белоусов В. В., Высоких М. Ю., ЗороT ва Л. Д., Исаев Н. К., Красников Б. Ф., Плотников Е. Ю. Друзья или враги. Активные формы кислорода и азота (обзор). Биохимия. 2005; 70 (2): 265—272.
(check this in PDF content)
14
Зоров Д. Б., Исаев Н. К., Плотников Е. Ю., Зорова Л. Д., Стельмашук Е. В., Васильева А. К., Архангельская А. А., Хряпенкова Т. Г. Митохондрия как многоликий Янус (обзор). Биохимия. 2007; 72 (10): 1371—1384.
(check this in PDF content)
15
Tondo L., Baldessarini R. J. Long!term lithium treatment in the preven! tion of suicidal behavior in bipolar disorder patients. Epidemiol. Psichiatr. Soc. 2009; 18 (3): 179—183.
(check this in PDF content)
16
Nonaka S., Chuang D. M. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport. 1998; 9 (9): 2081—2084.
(check this in PDF content)
17
Xu J., Culman J., Blume A., Brecht S., Gohlke P. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke. 2003; 34 (5): 1287—1292.
(check this in PDF content)
18
Ma J., Zhang G. Y. Lithium reduced N!methyl!D!aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD!95 in rat hippocampus following cerebral ischemia. Neurosci. Lett. 2003; 348 (3): 185—189.
(check this in PDF content)
19
Bian Q., Shi T., Chuang D. M., Qian Y. Lithium reduces ischemia! induced hippocampal CA1 damage and behavioral deficits in gerbils. Brain Res. 2007; 1184: 270—276.
(check this in PDF content)
20
ChaleckaTFranaszek E., Chuang D. M. Lithium activates the serine/thre! onine kinase Akt!1 and suppresses glutamate!induced inhibition of Akt!1 activity in neurons. Proc. Natl. Acad. Sci. USA. 1999; 96 (15): 8745—8750.
(check this in PDF content)
21
Roh M. S., Eom T. Y., Zmijewska A. A., De Sarno P., Roth K. A., Jope R. S. Hypoxia activates glycogen synthase kinase!3 in mouse brain in vivo: protection by mood stabilizers and imipramine. Biol. Psychiatry. 2005; 57 (3): 278—286.
(check this in PDF content)
22
Yan X. B., Wang S. S., Hou H. L., Ji R., Zhou J. N. Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav. Brain Res. 2007; 177 (2): 282—289.
(check this in PDF content)
23
Yan X. B., Hou H. L., Wu L. M., Liu J., Zhou J. N. Lithium regulates hip! pocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemia. Neuropharmacology. 2007; 53 (4): 487—495.
(check this in PDF content)
24
Yoshida S., Kirino T., Tamura A., Basugi N., Sano K. Lithium ion does not protect brain against transient ischemia in gerbils. Stroke. 1991; 22 (1): 84—89.
(check this in PDF content)
25
Ren M., Senatorov V. V., Chen R. W., Chuang D. M. Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc. Natl. Acad. Sci. USA. 2003; 100 (10): 6210—6215.
(check this in PDF content)
26
Kim Y. R., van Meer M. P., Tejima E., Murata Y., Mandeville J. B., Dai G., Chuang D. M., Rosen B. R., Lo E. H. Functional MRI of delayed chron! ic lithium treatment in rat focal cerebral ischemia. Stroke. 2008; 39 (2): 439—447.
(check this in PDF content)
27
Guo S., Arai K., Stins M. F., Chuang D. M., Lo E. H. Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astro! cytes. Stroke. 2009; 40 (2): 652—655.
(check this in PDF content)
28
Zhu Z. F., Wang Q. G., Han B. J., William C. P. Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice. Brain Res. Bull. 2010; 83 (5): 272—277.
(check this in PDF content)
29
Shapira M., Licht A., Milman A., Pick C. G., Shohami E., EldarTFinkelman H. Role of glycogen synthase kinase!3beta in early depressive behavior induced by mild traumatic brain injury. Mol. Cell. Neurosci. 2007; 34 (4): 571—577.
(check this in PDF content)
30
Dill J., Wang H., Zhou F., Li S. Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J. Neurosci. 2008; 28 (36): 8914—8928.
(check this in PDF content)
31
Yick L. W., So K. F., Cheung P. T., Wu W. T. Lithium chloride reinforces the regeneration!promoting effect of chondroitinase ABC on rubrospinal neurons after spinal cord injury. J. Neurotrauma. 2004; 21 (7): 932—943.
(check this in PDF content)
32
Faghihi M., Mirershadi F., Dehpour A. R., Bazargan M. Preconditioning with acute and chronic lithium administration reduces ischemia/reperfusion injury mediated by cyclooxygenase not nitric oxide synthase pathway in isolated rat heart. Eur. J. Pharmacol. 2008; 597 (1—3): 57—63.
(check this in PDF content)
33
Kaga S., Zhan L., Altaf E., Maulik N. Glycogen synthase kinase! 3beta/beta!catenin promotes angiogenic and anti!apoptotic signaling through the induction of VEGF, Bcl!2 and survivin expression in rat ischemic preconditioned myocardium. J. Mol. Cell Cardiol. 2006; 40 (1): 138—147.
(check this in PDF content)
34
Juhaszova M., Zorov D. B., Kim S. H., Pepe S., Fu Q., Fishbein K. W., Ziman B. D., Wang S., Ytrehus K., Antos C. L., Olson E. N., Sollott S. J. Glycogen synthase kinase!3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 2004; 113 (11): 1535—1549.
(check this in PDF content)
35
Talab S. S., Emami H., Elmi A., Nezami B. G., Assa S., Deroee A. F., Daneshmand A., Tavangar S. M., Dehpour A. R. Chronic lithium treat! ment protects the rat kidney against ischemia/reperfusion injury: the role of nitric oxide and cyclooxygenase pathways. Eur. J. Pharmacol. 2010; 647 (1—3): 171—177.
(check this in PDF content)
36
Васильева А. К., Плотников Е. Ю., Казаченко А. В., Кирпатовский В. И., Зоров Д. Б. Ингибирование GSK!3в снижает индуцированную ише! мией гибель клеток почки. Бюл. эксперим. биологии и медицины. 2010; 149 (3): 276—281.
(check this in PDF content)
37
Казаченко А. В., Дзеранов Н. К., Плотников Е. Ю., Голованов, С. А., Зоров Д. Б., Кирпатовский В. И. Механизм действия и эффектив! ность хлористого лития при тепловой ишемии почки. Урология. 2009; 4: 19—24.
(check this in PDF content)
38
Plotnikov E. Y., Kazachenko A. V., Vyssokikh M. Y., Vasileva A. K., Tc v i r k u n D . V . , I s a e v N . K . , K i r p a t o v s k y V . I . , Z o r o v D . B . The role of mitochondria in oxidative and nitrosative stress during ischemia/reper! fusion in the rat kidney. Kidney Int. 2007; 72 (12): 1493—1502.
(check this in PDF content)
39
Wang Y., Huang W. C., Wang C. Y., Tsai C. C., Chen C. L., Chang Y. T., Kai J. I., Lin C. F. Inhibiting glycogen synthase kinase!3 reduces endotoxaemic acute renal failure by down!regulating inflammation and renal cell apoptosis. Br. J. Pharmacol. 2009; 157 (6): 1004—1013.
(check this in PDF content)
40
Klein P. S., Melton D. A. A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA. 1996; 93 (16): 8455—8459.
(check this in PDF content)
41
Ryves W. J., Harwood A. J. Lithium inhibits glycogen synthase kinase!3 by competition for magnesium. Biochem. Biophys. Res. Commun. 2001; 280 (3): 720—725.
(check this in PDF content)
42
Stambolic V., Ruel L., Woodget J. R. Lithium inhibits glycogen synthase kinase!3 activity and mimics wingless signalling in intact cells. Curr. Biol. 1996; 6 (12): 1664—1668.
(check this in PDF content)
43
Jope R. S. A bimodal model of the mechanism of action of lithium. Mol. Psychiatry. 1999; 4 (1): 21—25.
(check this in PDF content)
44
Kirshenboim N., Plotkin B., Shlomo S. B., KaidanovichTBeilin O., EldarT Finkelman H. Lithium!mediated phosphorylation of glycogen synthase kinase!3beta involves PI3 kinase!dependent activation of protein kinase C!alpha. J. Mol. Neurosci. 2004; 24 (2): 237—245.
(check this in PDF content)
45
Zhang F., Phiel C. J., Spece L., Gurvich N., Klein P. S. Inhibitory phos! phorylation of glycogen synthase kinase!3 (GSK!3) in response to lithi! um. Evidence for autoregulation of GSK!3. J. Biol. Chem. 2003; 278 (35): 33067—33077.
(check this in PDF content)
46
Berridge M. J., Downes C. P., Hanley M. R. Neural and developmental actions of lithium: a unifying hypothesis. Cell. 1989; 59 (3): 411—419.
(check this in PDF content)
47
Fisher S. K., Agranoff B. W. Receptor activation and inositol lipid hydrolysis in neural tissues. J. Neurochem. 1987; 48 (4): 999—1017.
(check this in PDF content)
48
Phiel C. J., Klein P. S. Molecular targets of lithium action. Annu. Rev. Pharmacol. Toxicol. 2001; 41: 789—813.
(check this in PDF content)
49
Gould T. D., Quiroz J. A., Singh J., Zarate C. A., Manji H. K. Emerging experimental therapeutics for bipolar disorder: insights from the mole! cular and cellular actions of current mood stabilizers. Mol. Psychiatry. 2004; 9 (8): 734—755.
(check this in PDF content)
50
Sherman W. R., Gish B. G., Honchar M. P., Munsell L. Y. Effects of lithi! um onphosphoinositide metabolism in vivo. Fed. Proc. 1986; 45 (11): 2639—2646.
(check this in PDF content)
51
Martinez R. P., Raffa R. B. LiCl attenuates M(1)AChR!mediated intrathecal pilocarpine!induced reciprocal hindlimb scratching in mice. Pharmacology. 2002; 65 (4): 210—214.
(check this in PDF content)
52
Williams R. S., Cheng L., Mudge A. W., Harwood A. J. A common mecha! nism of action for three mood!stabilizing drugs. Nature. 2002; 417 (6886): 292—295.
(check this in PDF content)
53
Centeno F., Mora A., Fuentes J. M., Soler G., Claro E. Partial lithium!asso! ciated protection against apoptosis induced by C2—ceramide in cere! bellar granule neurons. Neuroreport. 1998; 9 (18): 4199—4203.
(check this in PDF content)
54
Nonaka S., Hough C. J., Chuang D. M. Chronic lithium treatment robustly protects neurons in the central nervous system against excito! toxicity by inhibiting N!methyl!D!aspartate receptor!mediated calci! um influx. Proc. Natl. Acad. Sci. USA. 1998; 95 (5): 2642—2647.
(check this in PDF content)
55
Nonaka S., Katsube N., Chuang D. M. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J. Pharmacol. Exp. Ther. 1998; 286 (1): 539—547.
(check this in PDF content)
56
Hashimoto R., Hough C., Nakazawa T., Yamamoto T., Chuang D. M. Lithium protection against glutamate excitotoxicity in rat cerebral cortical neu! rons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. J. Neurochem. 2002; 80 (4): 589—597.
(check this in PDF content)
57
Hashimoto R., Fujimaki K., Jeong M. R., Christ L., Chuang D. M. Lithium! induced inhibition of Src tyrosine kinase in rat cerebral cortical neu! rons: a role in neuroprotection against N!methyl!D!aspartate receptor! mediated excitotoxicity. FEBS Lett. 2003; 538 (1—3): 145—148.
(check this in PDF content)
58
Hashimoto R., Senatorov V., Kanai H., Leeds P., Chuang D. M. Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience. 2003; 117 (1): 55—61.
(check this in PDF content)
59
Liu Y., Zhang G., Gao C., Hou X. NMDA receptor activation results in tyrosine phosphorylation of NMDA receptor subunit 2A(NR2A) and interaction of Pyk2 and Src with NR2A after transient cerebral ischemia and reperfusion. Brain Res. 2001; 909 (1—2): 51—58.
(check this in PDF content)
60
Takagi N., Shinno K., Teves L., Bissoon N., Wallace M. C., Gurd J. W. Transient ischemia differentially increases tyrosine phosphorylation of NMDA receptor subunits 2A and 2B. J. Neurochem. 1997; 69 (3): 1060—1065.
(check this in PDF content)
61
Hou X. Y., Zhang G. Y., Yan J. Z., Chen M., Liu Y. Activation of NMDA receptors and L!type voltage!gated calcium channels mediates enhanced formation of Fyn!PSD95—NR2A complex after transient brain ischemia. Brain Res. 2002; 955 (1—2): 123—132.
(check this in PDF content)
62
Mielke K., Herdegen T. JNK and p38 stresskinases—degenerative effec! tors of signal!transduction!cascades in the nervous system. Prog. Neurobiol. 2000; 61 (1): 45—60.
(check this in PDF content)
63
Shaulian E., Karin M. AP!1 as a regulator of cell life and death. Nat. Cell. Biol. 2002; 4 (5): E131—E136.
(check this in PDF content)
64
Whitmarsh A. J., Davis R. J. Transcription factor AP!1 regulation by mitogen!activated protein kinase signal transduction pathways. J. Mol. Med. (Berl). 1996; 74 (10): 589—607.
(check this in PDF content)
65
Chen R. W., Qin Z. H., Ren M., Kanai H., ChaleckaTFranaszek E., Leeds P., Chuang D. M. Regulation of c!Jun N!terminal kinase, p38 kin4ase and AP!1 DNA binding in cultured brain neurons: roles in glutamate exci! totoxicity and lithium neuroprotection. J. Neurochem. 2003; 84 (3): 566—575.
(check this in PDF content)
66
Huang E. J., Reichardt L. F. Trk receptors: roles in neuronal signal trans! duction. Annu. Rev. Biochem. 2003; 72: 609—642.
(check this in PDF content)
67
Brunet A., Datta S. R., Greenberg M. E. Transcription!dependent and — independent control of neuronal survival by the PI3K!Akt signaling pathway. Curr. Opin. Neurobiol. 2001; 11 (3): 297—305.
(check this in PDF content)
68
Chang F., Steelman L. S., Shelton J. G., Lee J. T., Navolanic P. M., Blalock W. L., Franklin R., McCubrey J. A. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. Int. J. Oncol. 2003; 22 (3): 469—480.
(check this in PDF content)
69
Alessi D. R., Cohen P. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev. 1998; 8 (1): 55—62.
(check this in PDF content)
70
Neri L. M., Borgatti P., Capitani S., Martelli A. M. The nuclear phospho! inositide 3—kinase/AKT pathway: a new second messenger system. Biochim. Biophys. Acta. 2002; 1584 (2—3): 73—80.
(check this in PDF content)
71
Sarno P., Li X., Jope R. S. Regulation of Akt and glycogen synthase kinase!3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology. 2002; 43 (7): 1158—1164.
(check this in PDF content)
72
Fukumoto T., Morinobu S., Okamoto Y., Kagaya A., Yamawaki S. Chronic lithium treatment increases the expression of brain!derived neu! rotrophic factor in the rat brain. Psychopharmacology (Berl). 2001; 158 (1): 100—106.
(check this in PDF content)
73
Yasuda S., Liang M. H., Marinova Z., Yahyavi A., Chuang D. M. The mood stabilizers lithium and valproate selectively activate the promot! er IV of brain!derived neurotrophic factor in neurons. Mol. Psychiatry. 2009; 14 (1): 51—59.
(check this in PDF content)
74
Hashimoto R., Takei N., Shimazu K., Christ L., Lu B., Chuang DM. Lithium induces brain!derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology. 2002; 43 (7): 1173—1179.
(check this in PDF content)
75
Kutcher M. E., Klagsbrun M., Mamluk R. VEGF is required for the main! tenance of dorsal root ganglia blood vessels but not neurons during development. FA S E B J . 2004; 18 (15): 1952—1954.
(check this in PDF content)
76
Hendrick J. P., Hartl F. U. Molecular chaperone functions of heat!shock proteins. Annu. Rev. Biochem. 1993; 62: 349—384.
(check this in PDF content)
77
Bijur G. N., Jope R. S. Opposing actions of phosphatidylinositol 3!kinase and glycogen synthase kinase!3beta in the regulation of HSF!1 activi! ty. J. Neurochem. 2000; 75 (6): 2401—2408.
(check this in PDF content)